title: Antiangiogenic therapy of breast cancer: how did we get here?: the road not taken.
authors.forename: E
authors.initials: E
authors.lastname: Alba
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D040262:Receptors, Vascular Endothelial Growth Factor
references.citation: J Clin Invest. 2003 May;111(9):1287-95
references.pmid: 12727920
references.citation: J Clin Oncol. 2005 Feb 10;23(5):939-52
references.pmid: 15557593
references.citation: Science. 2005 Jan 7;307(5706):58-62
references.pmid: 15637262
references.citation: Nature. 2011 May 19;473(7347):298-307
references.pmid: 21593862
references.citation: Semin Cancer Biol. 2011 Jun;21(3):200-6
references.pmid: 21511035
references.citation: Ther Adv Med Oncol. 2011 Mar;3(2):85-93
references.pmid: 21789158
references.citation: Lancet Oncol. 2010 Dec;11(12):1172-83
references.pmid: 21126687
references.citation: Bioessays. 2007 Nov;29(11):1159-68
references.pmid: 17935210
references.citation: Cancer Cell. 2005 Oct;8(4):299-309
references.pmid: 16226705
references.citation: Clin Transl Oncol. 2011 Nov;13(11):805-8
references.pmid: 22082645